METHOTREXATE

NDC 55150-513 · Eugia US LLC

Generic nameMETHOTREXATE

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)METHOTREXATE SODIUM

Strength250 mg/10mL

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryANDA

Packages

55150-513-01 — 1 VIAL in 1 CARTON (55150-513-01) / 10 mL in 1 VIAL

FDA lists these products with the same active ingredient.

50090-5457 — Methotrexate, 51079-670 — methotrexate, 51285-366 — Methotrexate, 51285-367 — Methotrexate, 51285-368 — Methotrexate, 51285-369 — Methotrexate, 51407-121 — methotrexate, 55150-510 — METHOTREXATE, 55150-511 — METHOTREXATE, 55150-512 — METHOTREXATE, 59137-505 — methotrexate, 59137-510 — methotrexate, 59137-515 — methotrexate, 59137-520 — methotrexate, 59137-525 — methotrexate, 59137-530 — methotrexate, 59137-535 — methotrexate, 59137-540 — methotrexate, 59137-550 — methotrexate, 59651-182 — Methotrexate, +34 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.